ABCG2 and acute myeloid leukemia: Notably, the quantity of m7G sites in drug-resistant AML cells is significantly greater than that in AML cells, and its down-methylated m7G modification is specifically enriched in ABC transporter-related mRNAs, which are known to contribute to multidrug resistance11.